Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Testosterone 16.2mg/g gel (20.25mg per actuation)
0604020K0AABQBQ
|
Testosterone | Testosterone | Endocrine System | 27,661 |
|
Testogel 16.2mg/g gel
0604020K0BHABBQ
|
Testogel | Testosterone | Endocrine System | 23,676 |
|
Tostran 2% gel
0604020K0BMAABM
|
Tostran | Testosterone | Endocrine System | 20,140 |
|
Testosterone 40.5mg/2.5g transdermal gel unit dose sachets
0604020K0AABSBS
|
Testosterone | Testosterone | Endocrine System | 15,341 |
|
Testosterone 2% transdermal gel (10mg per actuation)
0604020K0AABMBM
|
Testosterone | Testosterone | Endocrine System | 13,989 |
|
Testogel 40.5mg/2.5g transdermal gel sachets
0604020K0BHACBS
|
Testogel | Testosterone | Endocrine System | 11,051 |
|
Testavan 20mg/g transdermal gel
0604020K0BQAABR
|
Testavan | Testosterone | Endocrine System | 5,322 |
|
Testosterone 50mg/5g transdermal gel unit dose sachets
0604020K0AABHBH
|
Testosterone | Testosterone | Endocrine System | 4,350 |
|
Testogel 50mg/5g transdermal gel sachets
0604020K0BHAABH
|
Testogel | Testosterone | Endocrine System | 3,053 |
|
Testosterone 20mg/g gel (23mg per actuation) with applicator
0604020K0AABRBR
|
Testosterone | Testosterone | Endocrine System | 2,042 |
|
Testosterone 50mg/5g transdermal gel unit dose tube
0604020K0AABKBK
|
Testosterone | Testosterone | Endocrine System | 388 |
|
Testim 50mg/5g transdermal gel
0604020K0BKAABK
|
Testim | Testosterone | Endocrine System | 251 |
|
Androfeme 1% cream
0604020K0BRAABT
|
Androfeme | Testosterone | Endocrine System | 141 |
|
Testosterone 20mg/g gel (23mg per actuation) refill
0604020K0AABUBU
|
Testosterone | Testosterone | Endocrine System | 69 |
|
Testavan 20mg/g transdermal gel refill
0604020K0BQABBU
|
Testavan | Testosterone | Endocrine System | 57 |
|
Testosterone 1% cream
0604020K0AABTBT
|
Testosterone | Testosterone | Endocrine System | 52 |
|
Testosterone 300micrograms/24hours transdermal patches
0604020K0AABLBL
|
Testosterone | Testosterone | Endocrine System | 2 |
|
Androderm 5mg/24hours transdermal patches
0604020K0BNAABC
|
Androderm | Testosterone | Endocrine System | No data available |
|
Andropatch 2.5mg/24hours patches
0604020K0BEAAA8
|
Andropatch | Testosterone | Endocrine System | No data available |
|
Andropatch 5mg/24hours patches
0604020K0BEABBC
|
Andropatch | Testosterone | Endocrine System | No data available |
|
Intrinsa 300micrograms/24hours transdermal patches
0604020K0BLAABL
|
Intrinsa | Testosterone | Endocrine System | No data available |
|
Striant SR 30mg muco-adhesive buccal tablets
0604020K0BJAABI
|
Striant | Testosterone | Endocrine System | No data available |
|
Testoderm 6mg/24hours patches
0604020K0BDAAA9
|
Testoderm | Testosterone | Endocrine System | No data available |
|
Testopatch 2.4mg/24hours transdermal patches
0604020K0BPAABP
|
Testopatch | Testosterone | Endocrine System | No data available |
|
Testosterone 1% ointment
0604020K0AAAJAJ
|
Testosterone | Testosterone | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.